GeoVax CEO David Dodd attended several conferences in Europe in 2H25 & heard concerns from stakeholders regarding a resurgence in previously considered eradicated viruses. We review measles, polio & whooping cough.
$GOVX
#biotech #biotechnology #science #GeoVax #Vaccines
youtu.be/QMri80C_A8s

#CEO David Dodd looks at the possible futures for GeoVax and the company’s focus during a surge in M&A activity.
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch #Oncology #InnovativeMedicine #Biotech #TargetedTherapy

GeoVax' #CEO David A. Dodd looks at the Modified Vaccinia Ankara (MVA) platform & how $GOVX is adapting it to be used in developing and developed regions alike.
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch #Oncology

GeoVax #CEO David Dodd explains why there has been a re-emergence of measles in the United States and other developed regions.
$GOVX
#biotech #biotechnology #science #GeoVax

GeoVax #CEO David Dodd emphasizes the importance of a multi-antigen vaccine. He calls for Congress to act in support of domestic biomanufacturing and biodevelopment.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #GeneTherapy #CancerResearch #Oncology #InnovativeMedicine #Biotech

GeoVax CEO David Dodd compares the US and China's #biotech industries & shares steps to take to maintain our leading position.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch

GeoVax CEO David Dodd shares his management philosophy in the face of substantial change in the healthcare environment.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #InnovativeMedicine #Biotech #TargetedTherapy #Immunotherapy #OrphanDrug #ClinicalTrials #CancerTreatment

CEO David Dodd shares GeoVax' strategy for generating value driven by clinical development milestones.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #Oncology #InnovativeMedicine #Biotech #TargetedTherapy #Immunotherapy #OrphanDrug #ClinicalTrials #CancerTreatment

Vaccines Weekly Update – June 20th 2025 Dengue, RSV, Mpox, Shigella & More | June 2025 Vaccine Breakthroughs 🌍💉🧠 This week’s edition of Vaccine Research Updates brings […] The post Vaccines Weekly Update – June 20th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Vaccines Weekly Update – June 20th 2025 #News #DengueVaccine #GeoVax #Moderna #Mpoxvaccine Comment below!

Vaccines Weekly Update – June 20th 2025 Dengue, RSV, Mpox, Shigella & More | June 2025 Vaccine Breakthroughs 🌍💉🧠 This week’s edition of Vaccine Research Updates brings […] The post Vaccines Weekly Update – June 20th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Vaccines Weekly Update – June 20th 2025 #News #DengueVaccine #GeoVax #Moderna #Mpoxvaccine Comment below!

Vaccines Weekly Update – June 20th 2025 Dengue, RSV, Mpox, Shigella & More | June 2025 Vaccine Breakthroughs 🌍💉🧠 This week’s edition of Vaccine Research Updates brings […] The post Vaccines Weekly Update – June 20th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Vaccines Weekly Update – June 20th 2025 #News #DengueVaccine #GeoVax #Moderna #Mpoxvaccine Comment below!

GeoVax Stock Jumps 28% on EMA Backing for Streamlined Path to Mpox/Smallpox Vaccine Approval Shares of GeoVax Labs (NASDAQ: GOVX) closed up 28% after the company announced positive regulatory guidance from the European Medicines Agency (EMA) supportin

#GOVX is gaining momentum after receiving backing from the European Medicines Agency for a streamlined path to approval of its MVA-based vaccine targeting mpox and smallpox. A major regulatory boost for global health and investor confidence.
#Geovax
prismmarketview.com/geovax-stock...